Ultrafast Short-acting Beta Blocker Esmolol (Brevibloc (R) ) for Perioperative Myocardial Protection
Authors:
Jurenka B . 1; O. Biebl 2; V. Kubricht 1; M. Stern 1; J. Šoupal 2
Authors‘ workplace:
Úsek kardiovaskulární anestezie a intenzivní péce, Nemocnice Na Homolce Praha, primár MUDr. Milan Rocen 2 Kardiovaskulární chirurgie, Nemocnice Na Homolce Praha, primár MUDr. Pavel Šebesta, CSc.
1
Published in:
Anest. intenziv. Med., , 2002, č. 3, s. 100-102
Category:
Overview
The authors deal with the complex pharmacological control of sympathetic activation in high risk patients in the risk for the perioperative myocardialischemia. As the part of the perioperative myocardial protection the authors present ultrafast short-acting beta blocker esmolol (Brevibloc ). Itsapplication, as the part of the complex myocardial protection, decreases incidence of the perioperative myocardial ischemia in patients with theabdominal aortic surgery.
Key words:
perioperative myocardial ischemia – abdominal aortic surgery, – perioperative control of sympathetic activation, – myocardial protection
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2002 Issue 3
Most read in this issue
- TUR Syndrome – Case Reports
- Bronchoalveolar Lavage as a Therapeutic Way for Alveolar Proteinosis
- Patient with Haematologic Malignity and Sepsis with Multiorgan Failure
- Ultrafast Short-acting Beta Blocker Esmolol (Brevibloc (R) ) for Perioperative Myocardial Protection